IP Library Granted Patent US 7,531,005
Granted Patent B1
US 7,531,005 · App. 09/913,139 · Granted May 12, 2009

Biodegradable composite material for tissue repair

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,531,005
App. No.
09/913,139
Granted
May 12, 2009
Kind
B1
Abstract

There is described a biodegradable composite material for tissue repair comprising a water-soluble glass, preferably as glass fibers and/or particles in the form of a matrix, impregnated with a biodegradable polymer. An especially preferred polymer is poly ε-caprolactone. The biodegradable composite is particularly useful for the repair of nerve and/or bone tissue, especially the bones of the skull. A method of producing the composite material is also described.

Claims (23)

1. A biodegradable composite material suitable for implantation into a patient's body, said composite material comprising water soluble glass fibers and a biodegradable polymer, wherein said water soluble glass fibers comprise from 30 mole % to less than 85 mole % of phosphorous pentoxide, and wherein said water soluble glass fibers comprise a mixture of water soluble glass fibers and water soluble glass particles.

2. The composite material as claimed in claim 1 , wherein said biodegradable polymer is a polyvinyl alcohol, polysaccharide, polyglycolic acid, polylactic acid, polyhydroxybutyrate, polyhydroxyvaleriate, polycaprolactone, polycaprolactam or a starch.

3. The composite material as claimed in claim 2 , wherein said biodegradable polymer is poly ε-caprolactone.

4. The composite material as claimed in claim 1 , which comprises a matrix of a mixture of water soluble glass fibers and water soluble glass particles, impregnated with said biodegradable polymer.

5. The composite material as claimed in claim 2 , wherein said biodegradable polymer is a starch.

6. The composite material as claimed in claim 5 , wherein the starch is selected from the group consisting of a thermoplastic starch, a hydroxypropylated starch, a potato starch, a maize starch, and a rice starch.

7. The biodegradable composite material as claimed in claim 1 , further comprising an antimicrobial material.

8. The biodegradable composite material as claimed in claim 1 , further comprising a metal selected from the group consisting of copper magnesium, zinc, cerium, manganese, bismuth, selenium, cesium, and mixtures thereof.

9. The biodegradable composite material as claimed in claim 1 , further comprising a source of silver ions.

10. The biodegradable composite material as claimed in claim 9 , wherein the biodegradable polymer is a starch.

11. The biodegradable composite material as claimed in claim 1 , wherein the water soluble glass fibers further comprise a metal selected from the group consisting of silver, copper, magnesium, zinc, cerium, manganese, bismuth, selenium, cesium, and mixtures thereof.

12. The biodegradable composite material as claimed in claim 11 , wherein the biodegradable polymer is a starch.

13. A method of producing a composite material suitable for tissue repair, said method comprising:

a) providing a mixture of water soluble glass fibers and water soluble glass particles comprising from 30 mole % to less than 85 mole % of phosphorous pentoxide;

b) optionally arranging said mixture into a pre-selected order; and

c) covering said mixture with a biodegradable polymer and if required allowing said polymer to cure.

14. The method as claimed in claim 13 , wherein said biodegradable polymer is poly ε-caprolactone and wherein polymerisation occurs within a mould.

15. A method of repairing an area of defective tissue in a patient, said method comprising inserting a biodegradable composite material suitable for, implantation into a patient's body, said composite material comprising water soluble glass fibers and a biodegradable polymer into said patient in a quantity sufficient to cover and/or fill said area, wherein said water soluble glass fibers comprise from 30 mole % to less than 85 mole % of phosphorous pentoxide, and wherein said composite material comprises a mixture of water soluble glass fibers and water soluble glass particles.

16. The method as claimed in claim 15 , wherein the area of defective tissue is an area of nerve or bone in need of repair.

17. The method as claimed in claim 15 , wherein said composite material is attached to healthy tissue by suture and/or by biodegradable adhesive.

18. The method of claim 9 , wherein said biodegradable polymer is a polyvinyl alcohol, polysaccharide, polyglycolic acid, polylactic acid, polyhydroxybutyrate, polyhydroxyvaleriate, polycaprolactone, polycaprolactam or a starch.

19. The method of claim 9 , wherein said biodegradable polymer is poly ε-caprolactone.

20. The method of claim 15 , wherein said composite material comprises a matrix of a mixture of water soluble glass fibers and water soluble glass particles impregnated with said biodegradable polymer.

Assignments (4)
CHANGE OF NAME Recorded May 17, 2013
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 030427/0385 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2005
From: GILTECH LIMITED
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 015519/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2005
From: HEALY, DAVID M; GILCHRIST, THOMAS
To: GILTECH LIMITED
Reel/Frame 015519/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2004
From: GILTECH LIMITED
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 015341/0444 →